一个年轻女子的胸:医疗管理的困难
Eleanor C Barton1, Simon Johnson2, Neil Collin1
1Academic Respiratory Unit North Bristol NHS Trust Bristol UK.
Respirology case reports
|February 19, 2024
概括
淋巴结核病 (Lymphangioleiomyomatosis,简称LAM) 是女性罕见的肺病. 一项成功的治疗结合了mTOR抑制剂和干预性放射学,用于管理LAM的并发症胆胸部.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 淋巴结核病 (Lymphangioleiomyomatosis,简称LAM) 是一种罕见的,进展性肺部疾病,主要影响生育年龄的妇女.
- 胸腔内淋巴液的积累,即胸腔内淋巴液的积累,是LAM的已知并发症.
- 目前对LAM相关的胆胸的管理策略缺乏定义,并且成功率有限,往往需要专门的中心.
研究的目的:
- 描述一个年轻女子患有LAM的二次胆胸病例.
- 评估一种涉及mTOR抑制剂和干预放射学的联合治疗方法的有效性.
- 为突出这种罕见并发症的潜在管理策略.
主要方法:
- 一个案例报告说,一名年轻女子因为LAM而出现状溢液.
- 进行了初步的医疗管理和经常性排水程序.
- 治疗最终升级为mTOR抑制剂和干预性放射技术的组合.
主要成果:
- 最初的医疗管理和排水程序没有成功,导致并发症.
- 结合mTOR抑制剂和干预性放射学的结合导致了流的缓解.
- 这种多式模式的方法在管理LAM相关的耐火性肌胸病例方面取得了显著的成功.
结论:
- 在LAM中治疗胆胸部需要一个量身定制的,往往是积极的方法.
- 与干预性放射学相结合的mTOR抑制剂是实现缓解的有希望的策略.
- 这一案例凸显了罕见的肺部并发症多学科护理和先进技术的重要性.
相关概念视频
01:27Pneumothorax-II
146
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
146
01:26Endoscopic Studies II: Thoracocentesis
259
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
259
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26Flail Chest-II
169
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
169
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:28Pleural Effusion II: Symptoms and Management
173
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
173